Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Full Agenda Released for Ophthalmic Drugs 2017SMi Group are proud to present the launch of Ophthalmic Drugs
By: SMi Group With the Ophthalmic Drugs market being worth over $37bn in 2026 (Vision Gain), Ophthalmic Drugs 2017 will enable you to explore novel approaches into treatments, new developments in medical devices, drug delivery and pre-clinical and clinical trials in order to deepen your understanding of inherited ocular diseases. Here's a snap shot of our industry leading experts presenting this November: - Naj Sharif, Executive Director in R&D, Head, Global Alliances & External Research, Santen Inc - Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals - Michael Lai, Global Program Medical Director, Novartis - Sérgio Leal, Ophthalmologist Director, Global Clinical Leader, Bayer - Victor Chong, Global Head of Ophthalmology, Boehringer Ingelheim - Amir Shojaei, Vice President Therapeutic Area Head, Ophthalmology, Shire - Tomas Navratil, Senior Vice President, Development, Envisia Therapeutics Take a look at the full speaker line-up! www.ophthalmicdrugs.com/ Some of the key topics addressed will involve: - Novel approaches to the treatment of ocular diseases - Advancements in ophthalmic clinical trials - Combating challenges in drug release and delivery - Animal models and regulatory considerations - Commercial potential of ocular drugs and improved patient care For those looking to attend there is currently a £300 early bird saving, for a limited time only. Further information is available at: www.ophthalmicdrugs.com/ SMi is Proud to Present the Launch of… Ophthalmic Drugs Date: 28th – 29th November 2017 Location: London, UK Website: www.ophthalmicdrugs.com/ Sponsors: - EXPERIMENTICA - LEICA MICROSYSTEMS ---end--- Contact Information: For all media inquiries contact Pavan Solanki on Tel: +44 (0)20 7827 6048 / Email: psolanki@smi- About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to- End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|